Simon Cervenka

About me
Publications
CV
Public outreach and news

About me

I am an affilate researcher at Centre for psychiatry research
Medical degree, Uppsala University, 1999
Licence to practice medicine, 2002
PhD, Department of Clinical Neuroscience, Karolinska Institutet, 2008
Specialist in General Psychiatry, 2009
Guest Researcher, University of Cambridge, 2015-2016
Associate Professor in Psychiatry, 2016
Professor in Psychiatry, Uppsala University 2021

Research

My research is dedicated to finding new methods of diagnosis and treatment of
psychotic disorders. The main approach is to use Positron Emission
Tomography (PET) but extending also to other imaging modalities and
methods. The research is carried out in close collaboration with clincial partners and other research groups within KI.

Teaching

Articles

Journal article: SCHIZOPHRENIA RESEARCH: COGNITION. 2025;42:100387
Cognition before and after psychosis onset: A naturalistic study of change heterogeneity, and prognosis
Lee M; Cullen AE; Matheson GJ; Lu Z-A; Bergen SE; Sellgren CM; Erhardt S; Fatouros-Bergman H; Cervenka S
Journal article: MOLECULAR PSYCHIATRY. 2025;30(7):3323-3324
Response to: "Circular reasoning concerning red flags for predicting rituximab response in OCD"
Gallwitz M; Lindqvist I; Rasmusson AJ; Cervenka S; Burman J; Cunningham JL
Article: SCHIZOPHRENIA. 2025;11(1):88
Cardiovascular protein profiling in patients with first-episode psychosis
Malmqvist A; Eren F; Schwieler L; Orhan F; Fatouros-Bergman H; Flyckt L; Piehl F; Cervenka S; Baeck M; Sellgren CM; Engberg G; Erhardt S
Journal article: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2025;172:106133
From transdiagnostic risk prediction to personalized prevention in psychiatry: Designing studies to determine heterogeneity of treatment effects
Cervenka S; Sundstrom J
Article: MOLECULAR PSYCHIATRY. 2025;30(4):1396-1406
Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment
Gallwitz M; Lindqvist I; Mulder J; Rasmusson AJ; Larsson A; Husen E; Borin J; van der Spek PJ; Sabbagh N; Widgren A; Bergquist J; Cervenka S; Burman J; Cunningham JL
Article: BMJ MENTAL HEALTH. 2025;28(1):e301248
Prevalence and predictors of healthcare use for psychiatric disorders at 9 years after a first episode of psychosis: a Swedish national cohort study
van Deursen D; Mittendorfer-Rutz E; Taipale H; Pettersson E; Mcguire P; Fusar-Poli P; Joyce DW; Albert N; Erlangsen A; Nordentoft M; Hjorthoj C; Cervenka S; Cullen AE
Journal article: TRANSLATIONAL PSYCHIATRY. 2024;14(1):304
An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
Syk M; Tornvind E; Gallwitz M; Faellmar D; Amandusson A; Rothkegel H; Danfors T; Thulin M; Rasmusson AJ; Cervenka S; Pollak TA; Endres D; van Elst LT; Boden R; Nilsson BM; Nordmark G; Burman J; Cunningham JL
Article: JAMA PSYCHIATRY. 2024;81(5):468-476
Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis A Systematic Review and Meta-Analysis
Lee M; Cernvall M; Borg J; Plaven-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
Journal article: LANCET DIGITAL HEALTH. 2024;6(3):e211-e221
Normative modelling of brain morphometry across the lifespan with CentileBrain: algorithm benchmarking and model optimisation.
Ge R; Yu Y; Qi YX; Fan Y-N; Chen S; Gao C; Haas SS; New F; Boomsma DI; Brodaty H; Brouwer RM; Buckner R; Caseras X; Crivello F; Crone EA; Erk S; Fisher SE; Franke B; Glahn DC; Dannlowski U; Grotegerd D; Gruber O; Hulshoff Pol HE; Schumann G; Tamnes CK; Walter H; Wierenga LM; Jahanshad N; Thompson PM; Frangou S; ENIGMA Lifespan Working Group
Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2024;171:306-315
Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosis
Haroon H; Ho AM-C; Gupta VK; Dasari S; Sellgren CM; Cervenka S; Engberg G; Eren F; Erhardt S; Sung J; Choi D-S
Article: BRAIN BEHAVIOR AND IMMUNITY. 2024;117:313-319
Lower complement C1q levels in first-episode psychosis and in schizophrenia
Koskuvi M; Malwade S; Lekander JG; Horbeck E; Bruno S; Larsson JH; Pelanis A; Isgren A; Goulding A; Fatouros-Bergman H; Samudyata; Schalling M; Piehl F; Erhardt S; Landen M; Cervenka S; Orhan F; Sellgren CM
Article: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2023;77(12):665-671
Disrupted-in-schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first-episode psychosis
Pils M; Rutsch J; Eren F; Engberg G; Piehl F; Cervenka S; Sellgren C; Trossbach S; Willbold D; Erhardt S; Bannach O; Korth C
Journal article: JOURNAL OF AFFECTIVE DISORDERS REPORTS. 2023;13:100597
Experiences in implementing immunopsychiatry in real life
Cunningham JL; Nordmark G; Fällmar D; Cervenka S; Gallwitz M; Säll R; Schmidt PT; Rönnelid J; Persson B; Kindmark A; Burman J
Article: SCHIZOPHRENIA RESEARCH. 2023;257:34-40
CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance
Orhan F; Goiny M; Becklen M; Mathe L; Piehl F; Schwieler L; Fatouros-Bergman H; Farde L; Cervenka S; Sellgren CM; Engberg G; Erhardt S
Article: BRAIN BEHAVIOR AND IMMUNITY. 2023;111:376-385
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity
Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Article: ADDICTION. 2023;118(6):1053-1061
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers
Jangard S; Jayaram-Lindstrom N; Isacsson NH; Matheson GJ; Plaven-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(14):e2213880120
Large- scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Schijven D; Postema MC; Fukunaga M; Matsumoto J; Miura K; de Zwarte SMC; van Haren NEM; Cahn W; Pol HEH; Kahn RS; Ayesa-Arriola R; de la Foz VO-G; Tordesillas-Gutierrez D; Vazquez-Bourgon J; Crespo-Facorro B; Alnaes D; Dahl A; Westlye LT; Agartz I; Andreassen OA; Jonsson EG; Kochunov P; Bruggemann JM; Catts SV; Michie PT; Mowry BJ; Quide Y; Rasser PE; Schall U; Scott RJ; Carr VJ; Green MJ; Henskens FA; Loughland CM; Pantelis C; Weickert CS; Weickert TW; De Haan L; Brosch K; Pfarr J-K; Ringwald KG; Stein F; Jansen A; Kircher TTJ; Nenadic I; Kramer B; Gruber O; Satterthwaite TD; Bustillo J; Mathalon DH; Preda A; Calhoun VD; Ford JM; Potkin SG; Chen J; Tan Y; Wang Z; Xiang H; Fan F; Bernardoni F; Ehrlich S; Fuentes-Claramonte P; Garcia-Leon MA; Guerrero-Pedraza A; Salvador R; Sarro S; Pomarol-Clotet E; Ciullo V; Piras F; Vecchio D; Banaj N; Spalletta G; Michielse S; van Amelsvoort T; Dickie EW; Voineskos AN; Sim K; Ciufolini S; Dazzan P; Murray RM; Kim W-S; Chung Y-C; Andreou C; Schmidt A; Borgwardt S; McIntosh AM; Whalley HC; Lawrie SM; Du Plessis S; Luckhoff HK; Scheffler F; Emsley R; Grotegerd D; Lencer R; Dannlowski U; Edmond JT; Rootes-Murdy K; Stephen JM; Mayer AR; Antonucci LA; Fazio L; Pergola G; Bertolino A; Diaz-Caneja CM; Janssen J; Lois NG; Arango C; Tomyshev AS; Lebedeva I; Cervenkav S; Sellgrenv CM; Georgiadis F; Kirschner M; Kaiser S; Hajek T; Skoch A; Spaniel F; Kim M; Bin Kwak Y; Oh S; Kwon JS; James A; Bakker G; Knochel C; Stablein M; Oertel V; Uhlmann A; Howells FM; Stein DJ; Temmingh HS; Diaz-Zuluaga AM; Pineda-Zapata JA; Lopez-Jaramillo C; Homan S; Ji E; Surbeck W; Homan P; Fishera SE; Franke B; Glahn DC; Gur RC; Hashimoto R; Jahanshad N; Luders E; Medland SE; Thompson PM; Turner JA; van Erp TGM; Francks C
Journal article: JOURNAL OF AFFECTIVE DISORDERS REPORTS. 2023;12:100531
CNS damage biomarkers in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
Cunningham J; Syk M; Tornvind E; Gallwitz M; Fällmar D; Amandusson Å; Rothkegel H; Danfors T; Thulin M; Rasmusson AJ; Cervenka S; Pollack T; van Elst LT; Endres D; Bodén R; Nilsson BM; Burman J
Journal article: EUROPEAN PSYCHIATRY. 2023;66:s490-s491
General intelligence in adult patients with early- and adult-onset schizophrenia
Calkova T; Morch-Johnsen L; Smelror RE; Jorgensen KN; Cervenka S; Collste K; Vaskinn A; Myhre AM; Andreassen OA; Ueland T; Agartz I; Andreou D
Article: CLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2023;30(2):486-490
Metacognitive training for negative symptoms: Support for the cognitive model
Swanson L; Griffiths H; Moritz S; Cervenka S
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(14)
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Schijven D; Postema MC; Fukunaga M; Matsumoto J; Miura K; de Zwarte SMC; van Haren NEM; Cahn W; Pol HEH; Kahn RS; Ayesa-Arriola R; de la Foz VO-G; Tordesillas-Gutierrez D; Vazquez-Bourgoni J; Crespo-Facorro B; Alnaes D; Dahl A; Westlye LT; Agartz I; Andreassen OA; Jonsson EG; Kochunov P; Bruggemann JM; Catts SV; Michie PT; Mowry BJ; Quide Y; Rasser PE; Schall U; Scott RJ; Carr VJ; Green MJ; Henskens FA; Loughland CM; Pantelis C; Weickert CS; Weickert TW; de Haan L; Brosch K; Pfarr J-K; Ringwald KG; Stein F; Jansen A; Kircher TTJ; Nenadic I; Kramer B; Gruber O; Satterthwaite TD; Bustillo J; Mathalon DH; Preda A; Calhoun VD; Ford JM; Potkin SG; Chen J; Tan Y; Wang Z; Xiang H; Fan F; Bernardoni F; Ehrlich S; Fuentes-Claramonte P; Garcia-Leon MA; Guerrero-Pedraza A; Salvador R; Sarro S; Pomarol-Clotet E; Ciullo V; Piras F; Vecchio D; Banaj N; Spalletta G; Michielse S; van Amelsvoort T; Dickie EW; Voineskos AN; Sim K; Ciufolini S; Dazzan P; Murray RM; Kim W-S; Chung Y-C; Andreou C; Schmidt A; Borgwardt S; McIntosh AM; Whalley HC; Lawrie SM; du Plessis S; Luckhoff HK; Scheffler F; Emsley R; Grotegerd D; Lencer R; Dannlowski U; Edmond JT; Rootes-Murdy K; Stephen JM; Mayer AR; Antonucci LA; Fazio L; Pergola G; Bertolino A; Diaz-Caneja CM; Janssen J; Lois NG; Arango C; Tomyshev AS; Lebedeva I; Cervenka S; Sellgren CM; Georgiadis F; Kirschner M; Kaiser S; Hajek T; Skoch A; Spaniel F; Kim M; Bin Kwak Y; Oh S; Kwon JS; James A; Bakker G; Knochel C; Stablein M; Oertel V; Uhlmann A; Howells FM; Stein DJ; Temmingh HS; Diaz-Zuluaga AM; Pineda-Zapata JA; Lopez-Jaramillo C; Homan S; Ji E; Surbeck W; Homan P; Fisher SE; Franke B; Glahn DC; Gur RC; Hashimoto R; Jahanshad N; Luders E; Medland SE; Thompson PM; Turner JA; van Erp TGM; Francks C
Article: NEUROIMMUNOMODULATION. 2023;30(1):338-345
Olfactory cues of naturally occurring systemic inflammation: A pilot study of seasonal allergy
Tognetti A; Saluja S; Lybert N; Lasselin J; Tamm S; Lensmar C; Karshikoff B; Cervenka S; Lekander M; Olsson MJ
Article: NATURE COMMUNICATIONS. 2022;13(1):6427
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
Gracias J; Orhan F; Horbeck E; Holmen-Larsson J; Khanlarkani N; Malwade S; Goparaju SK; Schwieler L; Demirel IS; Fu T; Fatourus-Bergman H; Pelanis A; Goold CP; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yanez VAC; Gopfert JC; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan SD; Perlis RH; Cervenka S; Erhardt S; Landen M; Sellgren CM
Journal article: BJPSYCH OPEN. 2022;8(5):e176
Exhaustion disorder: scoping review of research on a recently introduced stress-related diagnosis (8, pg e159, 2022)
Lindsater E; Svardman F; Wallert J; Ivanova E; Soderholm A; Fondberg R; Nilsonne G; Cervenka S; Lekander M; Ruck C
Article: HELIYON. 2022;8(9):e10424
Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms
Larsson C; Lee M; Lundgren T; Erhardt S; Sellgren CM; Cervenka S; Borg J; Bolte S; Fatouros-Bergman H
Article: MOLECULAR PSYCHIATRY. 2022;27(8):3247-3261
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
Matlik K; Garton DR; Montano-Rodriguez AR; Olfat S; Eren F; Casserly L; Damdimopoulos A; Panhelainen A; Porokuokka LL; Kopra JJ; Turconi G; Schweizer N; Bereczki E; Piehl F; Engberg G; Cervenka S; Piepponen TP; Zhang F-P; Sipila P; Jakobsson J; Sellgren CM; Erhardt S; Andressoo J-O
Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2022;151:571-574
Cytomegalovirus infection associated with lower IQ in adolescent patients with schizophrenia spectrum disorders: A preliminary report
Calkova T; Cervenka S; Yolken RH; Andreassen OA; Andreou D
Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):229
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
Shang P; Ho AM-C; Tufvesson-Alm M; Lindberg DR; Grant CW; Orhan F; Eren F; Bhat M; Engberg G; Schwieler L; Fatouros-Bergman H; Imbeault S; Iverson RM; Dasari S; Piehl F; Cervenka S; Sellgren CM; Erhardt S; Choi D-S
Article: MOLECULAR PSYCHIATRY. 2022;27(2):1233-1240
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
Plaven-Sigray P; Ikonen Victorsson P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Sellgren CM; Erhardt S; Agartz I; Halldin C; Farde L; Cervenka S
Article: HUMAN BRAIN MAPPING. 2022;43(1):352-372
A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium
Gutman BA; van Erp TGM; Alpert K; Ching CRK; Isaev D; Ragothaman A; Jahanshad N; Saremi A; Zavaliangos-Petropulu A; Glahn DC; Shen L; Cong S; Alnaes D; Andreassen OA; Nhat TD; Westlye LT; Kochunov P; Satterthwaite TD; Wolf DH; Huang AJ; Kessler C; Weideman A; Nguyen D; Mueller BA; Faziola L; Potkin SG; Preda A; Mathalon DH; Bustillo J; Calhoun V; Ford JM; Walton E; Ehrlich S; Ducci G; Banaj N; Piras F; Piras F; Spalletta G; Canales-Rodriguez EJ; Fuentes-Claramonte P; Pomarol-Clotet E; Radua J; Salvador R; Sarro S; Dickie EW; Voineskos A; Tordesillas-Gutierrez D; Crespo-Facorro B; Setien-Suero E; van Son JM; Borgwardt S; Schoenborn-Harrisberger F; Morris D; Donohoe G; Holleran L; Cannon D; McDonald C; Corvin A; Gill M; Busatto Filho G; Rosa PGP; Serpa MH; Zanetti MV; Lebedeva I; Kaleda V; Tomyshev A; Crow T; James A; Cervenka S; Sellgren CM; Fatouros-Bergman H; Agartz I; Howells F; Stein DJ; Temmingh H; Uhlmann A; de ZGI; McMahon KL; Wright M; Cobia D; Csernansky JG; Thompson PM; Turner JA; Wang L
Article: HUMAN BRAIN MAPPING. 2022;43(1):431-451
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years
Frangou S; Modabbernia A; Williams SCR; Papachristou E; Doucet GE; Agartz I; Aghajani M; Akudjedu TN; Albajes-Eizagirre A; Alnaes D; Alpert KI; Andersson M; Andreasen NC; Andreassen OA; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buitelaar JK; Busatto GF; Buckner RL; Calhoun V; Canales-Rodriguez EJ; Cannon DM; Caseras X; Castellanos FX; Cervenka S; Chaim-Avancini TM; Ching CRK; Chubar V; Clark VP; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EA; Dale AM; Davey C; de Geus EJC; de Haan L; de ZGI; den Braber A; Dickie EW; Di Giorgio A; Nhat TD; Dorum ES; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher SE; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn DC; Gotlib IH; Grabe H-J; Grimm O; Groenewold NA; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Harrison BJ; Hartman CA; Hatton SN; Heinz A; Heslenfeld DJ; Hibar DP; Hickie IB; Ho B-C; Hoekstra PJ; Hohmann S; Holmes AJ; Hoogman M; Hosten N; Howells FM; Pol HEH; Huyser C; Jahanshad N; James A; Jernigan TL; Jiang J; Jonsson EG; Joska JA; Kahn R; Kalnin A; Kanai R; Klein M; Klyushnik TP; Koenders L; Koops S; Kraemer B; Kuntsi J; Lagopoulos J; Lazaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin NG; Martinez-Zalacain I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald BC; McIntosh AM; McMahon KL; McPhilemy G; Menchon JM; Medland SE; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik JE; Nyberg L; Oosterlaan J; de la Foz VO-G; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella MJ; Potkin SG; Radua J; Reif A; Rinker DA; Roffman JL; Rosa PGP; Sacchet MD; Sachdev PS; Salvador R; Sanchez-Juan P; Sarro S; Satterthwaite TD; Saykin AJ; Serpa MH; Schmaal L; Schnell K; Schumann G; Sim K; Smoller JW; Sommer I; Soriano-Mas C; Stein DJ; Strike LT; Swagerman SC; Tamnes CK; Temmingh HS; Thomopoulos SI; Tomyshev AS; Tordesillas-Gutierrez D; Trollor JN; Turner JA; Uhlmann A; van den Heuvel OA; van den Meer D; van der Wee NJA; van Haren NEM; van't Ent D; van Erp TGM; Veer IM; Veltman DJ; Voineskos A; Voelzke H; Walter H; Walton E; Wang L; Wang Y; Wassink TH; Weber B; Wen W; West JD; Westlye LT; Whalley H; Wierenga LM; Wittfeld K; Wolf DH; Worker A; Wright MJ; Yang K; Yoncheva Y; Zanetti MV; Ziegler GC; Thompson PM; Dima D
Article: HUMAN BRAIN MAPPING. 2022;43(1):452-469
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years
Dima D; Modabbernia A; Papachristou E; Doucet GE; Agartz I; Aghajani M; Akudjedu TN; Albajes-Eizagirre A; Alnaes D; Alpert KI; Andersson M; Andreasen NC; Andreassen OA; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buitelaar JK; Busatto GF; Buckner RL; Calhoun V; Canales-Rodriguez EJ; Cannon DM; Caseras X; Castellanos FX; Cervenka S; Chaim-Avancini TM; Ching CRK; Chubar V; Clark VP; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EA; Dale AM; Davey C; de Geus EJC; de Haan L; de ZGI; den Braber A; Dickie EW; Di Giorgio A; Nhat TD; Dorum ES; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher SE; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn DC; Gotlib IH; Grabe H-J; Grimm O; Groenewold NA; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Harrison BJ; Hartman CA; Hatton SN; Heinz A; Heslenfeld DJ; Hibar DP; Hickie IB; Ho B-C; Hoekstra PJ; Hohmann S; Holmes AJ; Hoogman M; Hosten N; Howells FM; Pol HEH; Huyser C; Jahanshad N; James A; Jernigan TL; Jiang J; Jonsson EG; Joska JA; Kahn R; Kalnin A; Kanai R; Klein M; Klyushnik TP; Koenders L; Koops S; Kraemer B; Kuntsi J; Lagopoulos J; Lazaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin NG; Martinez-Zalacain I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald BC; McIntosh AM; McMahon KL; McPhilemy G; Menchon JM; Medland SE; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik JE; Nyberg L; Oosterlaan J; Ortiz-Garcia De la Foz V; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella MJ; Potkin SG; Radua J; Reif A; Rinker DA; Roffman JL; Rosa PGP; Sacchet MD; Sachdev PS; Salvador R; Sanchez-Juan P; Sarro S; Satterthwaite TD; Saykin AJ; Serpa MH; Schmaal L; Schnell K; Schumann G; Sim K; Smoller JW; Sommer I; Soriano-Mas C; Stein DJ; Strike LT; Swagerman SC; Tamnes CK; Temmingh HS; Thomopoulos SI; Tomyshev AS; Tordesillas-Gutierrez D; Trollor JN; Turner JA; Uhlmann A; van den Heuvel OA; van den Meer D; van der Wee NJA; van Haren NEM; Van't Ent D; van Erp TGM; Veer IM; Veltman DJ; Voineskos A; Voelzke H; Walter H; Walton E; Wang L; Wang Y; Wassink TH; Weber B; Wen W; West JD; Westlye LT; Whalley H; Wierenga LM; Williams SCR; Wittfeld K; Wolf DH; Worker A; Wright MJ; Yang K; Yoncheva Y; Zanetti MV; Ziegler GC; Thompson PM; Frangou S
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):566
Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
Theorell J; Ramberger M; Harrison R; Mgbachi V; Jacobson L; Waters P; Erhardt S; Sellgren CM; Cervenka S; Piehl F; Irani SR
Article: MOLECULAR PSYCHIATRY. 2021;26(11):6820-6832
GRK3 deficiency elicits brain immune activation and psychosis
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schullman A; Goiny M; Svensson CI; Hokfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landen M; Engberg G; Erhardt S
Article: NPJ SCHIZOPHRENIA. 2021;7(1):46
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
Lee M; Fatouros-Bergman H; Plaven-Sigray P; Victorsson PI; Sellgren CM; Erhardt S; Flyckt L; Farde L; Cervenka S
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(5):315-322
Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences
Taipale H; Puranen A; Mittendorfer-Rutz E; Tiihonen J; Tanskanen A; Cervenka S; Lahteenvuo M
Article: NATURE AND SCIENCE OF SLEEP. 2021;13:775-789
Objective and Subjective Sleep in Rheumatoid Arthritis and Severe Seasonal Allergy: Preliminary Assessments of the Role of Sickness, Central and Peripheral Inflammation
Tamm S; Lensmar C; Andreasson A; Axelsson J; Moren AF; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Hoglund CO; Strand V; Cervenka S; Lekander M
Article: SCIENTIFIC REPORTS. 2021;11(1):7527
Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
Becklen M; Orhan F; Piehl F; Cervenka S; Sellgren CM; Flyckt L; Erhardt S; Fatouros-Bergman H
Article: JOURNAL OF NUCLEAR MEDICINE. 2021;62(3):412-417
Nondisplaceable Binding Is a Potential Confounding Factor in ¹¹C-PBR28 Translocator Protein PET Studies
Laurell GL; Plaven-Sigray P; Jucaite A; Varrone A; Cosgrove KP; Svarer C; Knudsen GM; Ogden RT; Zanderigo F; Cervenka S; Hillmer AT; Schain M
Article: NEUROIMAGE. 2021;226:117523
Low convergent validity of [¹¹C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [¹¹C]FLB 457
Freiburghaus T; Svensson JE; Matheson GJ; Plaven-Sigray P; Lundberg J; Farde L; Cervenka S
Article: BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING. 2020;5(12):1095-1103
Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study
Tonnesen S; Kaufmann T; de Lange A-MG; Richard G; Nhat TD; Alnaes D; van der Meer D; Rokicki J; Moberget T; Maximov II; Agartz I; Aminoff SR; Beck D; Barch DM; Beresniewicz J; Cervenka S; Fatouros-Bergman H; Craven AR; Flyckt L; Gurholt TP; Haukvik UK; Hugdahl K; Johnsen E; Jonsson EG; Kolskar KK; Kroken RA; Lagerberg TV; Loberg E-M; Nordvik JE; Sanders A-M; Ulrichsen K; Andreassen OA; Westlye LT
Article: EJNMMI RESEARCH. 2020;10(1):95
Reliability of dopamine transporter PET measurements with [¹⁸F]FE-PE2I in patients with Parkinson's disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Article: NATURE COMMUNICATIONS. 2020;11(1):4016
The genetic architecture of human brainstem structures and their involvement in common brain disorders
Elvsashagen T; Bahrami S; van der Meer D; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Beyer MK; Blasi G; Borgwardt S; Boye B; Buitelaar J; Boen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Di Carlo P; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman CA; Haberg A; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jonassen R; Jonsson EG; Kirsch P; Kloszewska I; Lagerberg TV; Landro NI; Le Hellard S; Lesch K-P; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; O'Connell KS; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin AA; Schmidt A; Schwarz E; Selbaek G; Soininen H; Sowa P; Steen VM; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Kaufmann T; Farde L; Flyckt L; Engberg G; Erhardt SS; Fatouros-Bergman H; Cervenka S; Schwieler L; Piehl F; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F; Sellgren CM
Article: SCHIZOPHRENIA RESEARCH. 2020;222:175-184
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plaven-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):77
Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(12):1756-1761
Synthesis and Preclinical Evaluation of 6-[¹⁸F]Fluorine-α- methyl-L-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake
Krasikova R; Kondrashov M; Avagliano C; Petukhov M; Vazquez-Romero A; Revunov E; Johnstrom P; Tari L; Toth M; Haggkvist J; Erhardt S; Cervenka S; Schou M
Article: IBRO REPORTS. 2020;8:136-142
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
Xu C; Sellgren CM; Fatouros-Bergman H; Piehl F; Blennow K; Zetterberg H; Brinkmalm A; Santillo AF; Lundgren S; Cervenka S; Engberg G; Erhardt S
Journal article: SCHIZOPHRENIA BULLETIN. 2020;46(Supplement_1):s233
T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
Plavén-Sigray P; Matheson G; Coughlin J; Hafizi S; Laurikainen H; Ottoy J; de’Picker L; Rusjan P; Hietala J; Howes O; Mizrahi R; Morrens M; Pomper M; Cervenka S
Journal article: SCHIZOPHRENIA BULLETIN. 2020;46(Supplement_1):s135-s136
M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
Victorsson P; Plavén-Sigray P; Matheson G; Santillo A; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Article: NEUROIMAGE. 2019;202:116143
Validity and reliability of extrastriatal [¹¹C]raclopride binding quantification in the living human brain
Svensson JE; Schain M; Plaven-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Article: NATURE NEUROSCIENCE. 2019;22(10):1617-1623
Common brain disorders are associated with heritable patterns of apparent aging of the brain
Kaufmann T; van der Meer D; Nhat TD; Schwarz E; Lund MJ; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Boen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Cordova-Palomera A; Dale AM; de Quervain DJF; Carlo P; Djurovic S; Dorum ES; Eisenacher S; Elvsashagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Haberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jernigan TL; Jonassen R; Jonsson EG; Kirsch P; Ktoszewska I; Kolskar KK; Landro NI; Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbaek G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Farde L; Flyckts L; Engberg G; Erhardt S; Fatouros-Bergmann H; Schwieler L; Piehl F; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(11):2329-2338
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [¹¹C]PBR28 HRRT PET study
Tuisku J; Plaven-Sigray P; Gaiser EC; Airas L; Al-Abdulrasul H; Bruck A; Carson RE; Chen M-K; Cosgrove KP; Ekblad L; Esterlis I; Farde L; Forsberg A; Halldin C; Helin S; Kosek E; Lekander M; Lindgren N; Marjamaki P; Rissanen E; Sucksdorff M; Varrone A; Collste K; Gallezot J-D; Hillmer A; Huang Y; Hoglund CO; Johansson J; Jucaite A; Lampa J; Nabulsi N; Pittman B; Sandiego CM; Stenkrona P; Rinne J; Matuskey D; Cervenka S
Article: JOURNAL OF NEUROIMMUNOLOGY. 2019;334:577000
Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [¹¹C]PBR28 positron emission tomography
Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Hoglund OC; Kosek E
Article: SCHIZOPHRENIA RESEARCH. 2019;210:221-227
Increased peripheral levels of TARC/CCL17 in first episode psychosis patients
Malmqvist A; Schwieler L; Orhan F; Fatouros-Bergman H; Bauer M; Flyckt L; Cervenka S; Engberg G; Piehl F; Erhardt S; Farde L; Flyckt L; Engberg G; Erhardt S; Fatouros-Bergman H; Cervenka S; Schwieler L; Piehl F; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: JAMA PSYCHIATRY. 2019;76(7):739-748
Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
Alnaes D; Kaufmann T; van der Meer D; Cordova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Nhat TD; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jonsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT; Farde L; Collste K; Victorsson P; Engberg G; Erhardt S; Malmqvist A; Hedberg M; Orhan F; Sellgren CM; Schwieler L; Piehl F
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(7):415-425
D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Article: NEUROIMAGE. 2019;188:102-110
Accuracy and reliability of [¹¹C]PBR28 specific binding estimated without the use of a reference region
Plaven-Sigray P; Schain M; Zanderigo F; Farde L; Halldin C; Forsberg A; Varrone A; Jucaite A; Cervenka S; Stenkrona P; Collste K; Kander M; Kosek E; Lampa J; Hoglund CO; Rabiner EA; Gunn RN; Ogden RT; Cervenk S
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):12
Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder
Schwarz E; Nhat TD; Pergola G; Westlye LT; Kaufmann T; Wolfers T; Brecheisen R; Quarto T; Ing AJ; Di Carlo P; Gurholt TP; Harms RL; Noirhomme Q; Moberget T; Agartz I; Andreassen OA; Bellani M; Bertolino A; Blasi G; Brambilla P; Buitelaar JK; Cervenka S; Flyckt L; Frangou S; Franke B; Hall J; Heslenfeld DJ; Kirsch P; McIntosh AM; Noethen MM; Papassotiropoulos A; de Quervain DJ-F; Rietschel M; Schumann G; Tost H; Witt SH; Zink M; Meyer-Lindenberg A; Bettella F; Brandt CL; Clarke T-K; Coynel D; Degenhardt F; Djurovic S; Eisenacher S; Fastenrath M; Fatouros-Bergman H; Forstner AJ; Frank J; Gambi F; Gelao B; Geschwind L; Di Giannantonio M; Di Giorgio A; Hartman CA; Heilmann-Heimbach S; Herms S; Hoekstra PJ; Hoffmann P; Hoogman M; Jonsson EG; Loos E; Maggioni E; Oosterlaan J; Papalino M; Rampino A; Romaniuk L; Selvaggi P; Sepede G; Sonderby IE; Spalek K; Sussmann JE; Thompson PM; Vasquez AA; Vogler C; Whalley H; Farde L; Flyckt L; Engberg G; Erhardt S; Fatouros-Bergman H; Cervenka S; Schwieler L; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: BRAIN BEHAVIOR AND IMMUNITY. 2019;75:72-83
Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation
Albrecht DS; Forsberg A; Sandstrom A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Hoglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
Article: PLOS ONE. 2018;13(12):e0209584
Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
Caravaggio F; Plaven-Sigray P; Matheson GJ; Plitman E; Chakravarty MM; Borg J; Graff-Guerrero A; Cervenka S
Article: EJNMMI RESEARCH. 2018;8(1):102
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plaven-Sigray P; Matheson GJ; Cselenyi Z; Jucaite A; Farde L; Cervenka S
Article: PEERJ. 2018;6:e5790
Serotonin 5-HT₁_A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(5):432-440
Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis
Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; Engberg G; Erhardt S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(9):644-654
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Bustillo JR; Clark VP; Agartz I; Mueller BA; Cahn W; de Zwarte SMC; Pol HEH; Kahn RS; Ophoff RA; van Haren NEM; Andreassen OA; Dale AM; Nhat TD; Gurholt TP; Hartberg CB; Haukvik UK; Jorgensen KN; Lagerberg TV; Melle I; Westlye LT; Gruber O; Kraemer B; Richter A; Zilles D; Calhoun VD; Crespo-Facorro B; Roiz-Santianez R; Tordesillas-Gutierrez D; Loughland C; Carr VJ; Catts S; Cropley VL; Fullerton JM; Green MJ; Henskens FA; Jablensky A; Lenroot RK; Mowry BJ; Michie PT; Pantelis C; Quide Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Weickert CS; Weickert TW; Morris DW; Hong E; Kochunov P; Beard LM; Gur RE; Gur RC; Satterthwaite TD; Wolf DH; Belger A; Brown GG; Ford JM; Macciardi F; Mathalon DH; O'Leary DS; Potkin SG; Preda A; Voyvodic J; Lim KO; McEwen S; Yang F; Tan Y; Tan S; Wang Z; Fan F; Chen J; Xiang H; Tang S; Guo H; Wan P; Wei D; Bockholt HJ; Ehrlich S; Wolthusen RPF; King MD; Shoemaker JM; Sponheim SR; De Haan L; Koenders L; Machielsen MW; van Amelsvoort T; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; McKenna PJ; Pomarol-Clotet E; Salvador R; Corvin A; Donohoe G; Kelly S; Whelan CD; Dickie EW; Rotenberg D; Voineskos AN; Ciufolini S; Radua J; Dazzan P; Murray R; Marques TR; Simmons A; Borgwardt S; Egloff L; Harrisberger F; Riecher-Roessler A; Smieskova R; Alpert KI; Wang L; Jonsson EG; Koops S; Sommer IEC; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Stephen JM; Kwon JS; Yun J-Y; Cannon DM; McDonald C; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Busatto GF; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; Hagenaars SP; McIntosh AM; Whalley HC; Lawrie SM; Knoechel C; Oertel-Knoechel V; Staeblein M; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; McMahon A; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA
Article: BIOLOGICAL PSYCHIATRY. 2018;84(6):433-442
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
Plaven-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Article: EJNMMI RESEARCH. 2018;8(1):74
[¹¹C]SCH23390 binding to the D₁-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis
Stenkrona P; Matheson GJ; Cervenka S; Sigray PP; Halldin C; Farde L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(22):E5154-E5163
Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium
Kong X-Z; Mathias SR; Guadalupe T; Glahn DC; Franke B; Crivello F; Tzourio-Mazoyer N; Fisher SE; Thompson PM; Francks C
Article: MOLECULAR PSYCHIATRY. 2018;23(5):1244-1250
CSF GABA is reduced in first-episode psychosis and associates to symptom severity
Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
Article: PLOS ONE. 2018;13(3):e0193770
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plaven-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Article: BRAIN BEHAVIOR AND IMMUNITY. 2018;68:146-157
Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [¹¹C]PBR28 PET study
Tamm S; Cervenka S; Forsberg A; Estelius J; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Lensmar C; Strand V; Akerstedt T; Halldin C; Ingvar M; Hoglund CO; Lekander M
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2018;10:678-687
In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.
Mak E; Bethlehem RAI; Romero-Garcia R; Cervenka S; Rittman T; Gabel S; Surendranathan A; Bevan-Jones RW; Passamonti L; Vázquez Rodríguez P; Su L; Arnold R; Williams GB; Hong YT; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT
Article: PSYCHOLOGICAL MEDICINE. 2018;48(1):82-94
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santianez R; Crespo-Facorro B; Suarez-Pinilla P; van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jorgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Jonsson EG; Hashimoto R; Yamamori H; Fukunaga M; Jahanshad N; De Rossi P; Piras F; Banaj N; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Kraemer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Journal article: BRAIN BEHAVIOR AND IMMUNITY. 2017;66:e34
Seasonal variation in central and peripheral inflammation in allergic subjects: A PET study
Lekander M; Tamm S; Cervenka S; Forsberg A; Lensmar C; Kosek E; Lampa J; Estelius J; Karshikoff B; Ingvar M; Höglund CO
Article: LECTURE NOTES IN COMPUTER SCIENCE. 2017;10541:371-378
Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging.
Petrov D; Gutman BA; Yu S-HJ; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite TD; Andreasen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutiérrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Ehrlich S; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rössler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodríguez EJ; Salvador R; Huang AJ; Roiz-Santiañez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Walton E; Thompson PM
Article: EJNMMI RESEARCH. 2017;7(1):58
Assessment of simplified ratio-based approaches for quantification of PET [¹¹C] PBR28 data
Matheson GJ; Plaven-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
Article: NEUROIMAGE. 2017;155:344-353
Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [¹¹C] SCH-23390
Matheson GJ; Stenkrona P; Cselenyi Z; Plaven-Sigray P; Halldin C; Farde L; Cervenka S
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_15):p760-p761
[P2–358]: IN VIVO MAPPING OF TAU DEPOSITION, PERFUSION, AND CORTICAL THINNING IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
Mak E; Gabel S; Cervenka S; Su L; Surendranathan A; Bevan‐Jones WR; Hong YT; Arnold R; Rodriguez PV; Jones S; Williams GB; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT; Passamonti L
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_25):p1236-p1237
[O4–04–04]: [18F]AV‐1451 PET IMAGING OF TAU PATHOLOGY PREDICTS WHITE MATTER HYPERINTENSITIES IN HEALTHY AGING, MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: THE NIMROD STUDY
Gabel S; Mak E; Cervenka S; Jones PS; Surendranathan A; Bevan‐Jones WR; Passamonti L; Rodriguez PV; Su L; Williams GB; Arnold R; Firbank MJ; Rowe JB; O'Brien JT
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_3):p140-p141
[IC‐P‐191]: IN VIVO MAPPING OF TAU DEPOSITION, PERFUSION, AND CORTICAL THINNING IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
Mak E; Gabel S; Cervenka S; Su L; Surendranathan A; Bevan‐Jones WR; Hong YT; Arnold R; Rodriguez PV; Jones S; Williams GB; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT
Article: MOLECULAR PSYCHIATRY. 2017;22(6):850-856
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [¹¹C]PBR28
Collste K; Plaven-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):462-469
Extrastriatal dopamine D2-receptor availability in social anxiety disorder
Plaven-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Ruck C; Halldin C; Lindefors N; Cervenka S
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2017;135(5):439-447
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santianez R; Crespo-Facorro B; Suarez-Pinilla P; Van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jorgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Jonsson EG; Hashimoto R; Yamamori H; Fukunaga M; Preda A; De Rossi P; Piras F; Banaj N; Ciullo V; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Kraemer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: TRANSLATIONAL PSYCHIATRY. 2017;7(4):e1104
Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study
Jayaram-Lindstrom N; Guterstam J; Haggkvist J; Ericson M; Malmlof T; Schilstrom B; Halldin C; Cervenka S; Saijo T; Nordstrom A-L; Franck J
Article: ANNALS OF NEUROLOGY. 2017;81(4):572-582
The Immune Response of the Human Brain to Abdominal Surgery
Forsberg A; Cervenka S; Fagerlund MJ; Rasmussen LS; Zetterberg H; Harris HE; Stridh P; Christensson E; Granstrom A; Schening A; Dymmel K; Knave N; Terrando N; Maze M; Borg J; Varrone A; Halldin C; Blennow K; Farde L; Eriksson LI
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;84(5):262-271
Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll-like Receptor Stimulation in Peripheral Monocytes
Orhan F; Bhat M; Sandberg K; Stahl S; Piehl F; Svensson C; Erhardt S; Schwieler L
Article: MOLECULAR PSYCHIATRY. 2016;21(8):1077-1084
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;54:149-157
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects
Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Hoglund CO; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(1):173-183
Test-retest reproducibility of [¹¹C]PBR28 binding to TSPO in healthy control subjects
Collste K; Forsberg A; Varrone A; Amini N; Aeinehband S; Yakushev I; Halldin C; Farde L; Cervenka S
Article: JAMA PSYCHIATRY. 2015;72(7):659-667
D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants A Randomized Clinical Trial
Andersson E; Hedman E; Enander J; Djurfeldt DR; Ljotsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Ruck C
Article: NEUROIMAGE. 2015;112:225-231
Diurnal and seasonal variation of the brain serotonin system in healthy male subjects
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Article: NEUROIMAGE. 2014;102:590-595
Dopamine D1 receptor availability is related to social behavior: A positron emission tomography study
Plaven-Sigray P; Gustavsson P; Farde L; Borg J; Stenkrona P; Nyberg L; Backman L; Cervenka S
Article: SCHIZOPHRENIA RESEARCH. 2014;158(1-3):156-162
Meta-analysis of cognitive performance in drug-naive patients with schizophrenia
Fatouros-Bergman H; Cervenka S; Flyckt L; Edman G; Farde L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(4):763-769
Effects of amphetamine on the human brain opioid system - a positron emission tomography study
Guterstam J; Jayaram-Lindstrom N; Cervenka S; Frost JJ; Farde L; Halldin C; Franck J
Article: NEUROIMAGE. 2013;67:1-6
Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum
de Manzano O; Cervenka S; Jucaite A; Hellenas O; Farde L; Ullen F
Article: TRANSLATIONAL PSYCHIATRY. 2012;2(5):e120
Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder
Cervenka S; Hedman E; Ikoma Y; Djurfeldt DR; Ruck C; Halldin C; Lindefors N
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:s55
P.3.004 Amphetamine-opioid interactions in the human brain reward system – a PET study using [11C]carfentanil
Guterstam J; Jayaram-Lindstrom N; Cervenka S; Halldin C; Farde L; Frost J; Franck J
Article: JOURNAL OF NEUROIMAGING. 2012;22(1):28-32
A Comparison of Gray Matter Density in Restless Legs Syndrome Patients and Matched Controls Using Voxel-Based Morphometry
Comley RA; Cervenka S; Palhagen SE; Panagiotidis G; Matthews JC; Lai RY; Halldin C; Farde L; Nichols TE; Whitcher BJ
Article: SYNAPSE-STRUCTURE FUNCTION CONNECTIVITY. 2010;64(6):478-485
PET Studies of D2-Receptor Binding in Striatal and Extrastriatal Brain Regions: Biochemical Support In Vivo for Separate Dopaminergic Systems in Humans
Cervenka S; Varrone A; Fransen E; Halldin C; Farde L
Article: PLOS ONE. 2010;5(5):e10670
Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals
de Manzano O; Cervenka S; Karabanov A; Farde L; Ullen F
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(16):7574-7579
Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning
Karabanov A; Cervenka S; de Manzano O; Forssberg H; Farde L; Ullen F
Article: NEUROIMAGE. 2010;50(1):323-328
Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability
Cervenka S; Gustavsson JP; Halldin C; Farde L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2008;11(5):671-678
Age-related diurnal effect on D₂ receptor binding: a preliminary PET study
Cervenka S; Halldin C; Farde L
Article: NEUROIMAGE. 2008;40(3):1287-1295
Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum
Cervenka S; Backman L; Cselenyi Z; Halldin C; Farde L
Article: LAKARTIDNINGEN. 2007;104(26-27):2002-2003
[Coming generation of researchers--a question of fate for psychiatry].
Cervenka S; Reutfors J; Lundberg J; Papadopoulos F; Lundén E; Sjöström C; Björklund L
Article: BRAIN. 2006;129(Pt 8):2017-2028
Support for dopaminergic hypoactivity in restless legs syndrome:: a PET study on D2-receptor binding
Cervenka S; Palhagen SE; Comley RA; Panagiotidis G; Cselenyi Z; Matthews JC; Lai RY; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2004;175(2):148-153
A cross-validation study on the relationship between central D₂ receptor occupancy and serum perphenazine concentration
Talvik M; Nordström AL; Larsen NE; Jucaite A; Cervenka S; Halldin C; Farde L
Show more

All other publications

Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2025;28:i35-i36
NO DIFFERENCES IN SYNAPTIC DENSITY IN TWINS WITH AUTISM AND THEIR NON-AUTISTIC CO-TWINS. HOWEVER, ARE DIFFERENCES IN SV2A BINDING POTENTIAL IN AUTISTIC BRAINS A MATTER OF WHITE MATTER?
Griffioen-Jarfalk G; Bolin M; Stephanov V; Cervenka S; Castelo-Branco M; Martins R; Lundberg J; Mehra C; Howes O; Murphy D; Bolte S; Farde L; Borg J
Preprint: MEDRXIV. 2024;MEDRXIV
Transdiagnostic alterations in white matter microstructure associated with suicidal thoughts and behaviours in the ENIGMA Suicidal Thoughts and Behaviours consortium.
van Velzen LS; Colic L; Ceja Z; Dauvermann MR; Villa LM; Savage HS; Toenders YJ; Dehestani N; Zhu AH; Campos AI; Salminen LE; Agartz I; Alexander N; Ayesa-Arriola R; Ballard ED; Banaj N; Barkhau C; Başgöze Z; Bauer J; Benedetti F; Berger K; Besteher B; Brosch K; Canal-Rivero M; Cervenka S; Colle R; Connolly CG; Corruble E; Courtet P; Couvy-Duchesne B; Crespo-Facorro B; Cullen KR; Dannlowski U; Deverdun J; Diaz-Zuluaga AM; Dietze LMF; Evans JW; Fani N; Flinkenflügel K; Friedman NP; Gotlib IH; Groenewold NA; Grotegerd D; Hajek T; Hatoum AS; Hermesdorf M; Hickie IB; Hirano Y; Ho TC; Ikemizu Y; Iorfino F; Ipser JC; Isobe Y; Jackowski AP; Jollant F; Kircher T; Klug M; Koopowitz S-M; Kraus A; Krug A; Le Bars E; Leehr EJ; Li M; Lippard ETC; Lopez-Jaramillo C; Maximov II; McIntosh AM; McLaughlin KA; McWhinney SR; Meinert S; Melloni E; Mitchell PB; Mwangi B; Nenadić I; Nerland S; Olie E; Ortiz-García de la Foz V; Pan PM; Pereira F; Piras F; Piras F; Poletti S; Reineberg AE; Roberts G; Romero-García R; Sacchet MD; Salum GA; Sandu A-L; Sellgren CM; Shimizu E; Smolker HR; Soares JC; Spalletta G; Douglas Steele J; Stein F; Stein DJ; Straube B; Teutenberg L; Thomas-Odenthal F; Usemann P; Valabregue R; Valencia-Echeverry J; Wagner G; Waiter G; Walter M; Whalley HC; Wu M-J; Yang TT; Zarate CA; Zugman A; Zunta-Soares GB; van Heeringen K; van Rooij SJH; van der Wee N; van der Werff S; Thompson PM; Blumberg HP; van Harmelen A-L; Rentería ME; Jahanshad N; ENIGMA Suicidal Thoughts and Behaviours Consortium; Schmaal L
Preprint: RESEARCH SQUARE. 2024
Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment
Cunningham J; Gallwitz M; Lindqvist I; Mulder J; Rasmusson A; Larsson A; Husén E; Borin J; Spek PVD; Sabbagh N; Widgren A; Bergquist J; Cervenka S; Burman J
Preprint: RESEARCH SQUARE. 2023
Damage markers in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
Cunningham J; Tornvind E; Syk M; Gallwitz M; Fällmar D; Amandusson Å; Rothkegel H; Danfors T; Thulin M; Rasmusson A; Cervenka S; Pollak T; Endres D; Elst LTV; Bodén R; Nilsson B; Nordmark G; Burman J
Preprint: BIORXIV. 2023;BIORXIV
Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization.
Ge R; Yu Y; Qi YX; Fan YV; Chen S; Gao C; Haas SS; Modabbernia A; New F; Agartz I; Asherson P; Ayesa-Arriola R; Banaj N; Banaschewski T; Baumeister S; Bertolino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buckner R; Buitelaar JK; Cannon DM; Caseras X; Cervenka S; Conrod PJ; Crespo-Facorro B; Crivello F; Crone EA; de Haan L; de Zubicaray GI; Di Giorgio A; Erk S; Fisher SE; Franke B; Frodl T; Glahn DC; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Harrison BJ; Hatton SN; Hickie I; Howells FM; Hulshoff Pol HE; Huyser C; Jernigan TL; Jiang J; Joska JA; Kahn RS; Kalnin AJ; Kochan NA; Koops S; Kuntsi J; Lagopoulos J; Lazaro L; Lebedeva IS; Lochner C; Martin NG; Mazoyer B; McDonald BC; McDonald C; McMahon KL; Nakao T; Nyberg L; Piras F; Portella MJ; Qiu J; Roffman JL; Sachdev PS; Sanford N; Satterthwaite TD; Saykin AJ; Schumann G; Sellgren CM; Sim K; Smoller JW; Soares J; Sommer IE; Spalletta G; Stein DJ; Tamnes CK; Thomopolous SI; Tomyshev AS; Tordesillas-Gutiérrez D; Trollor JN; van 't Ent D; van den Heuvel OA; van Erp TG; van Haren NE; Vecchio D; Veltman DJ; Walter H; Wang Y; Weber B; Wei D; Wen W; Westlye LT; Wierenga LM; Williams SC; Wright MJ; Medland S; Wu M-J; Yu K; Jahanshad N; Thompson PM; Frangou S
Letter: BRAIN BEHAVIOR AND IMMUNITY. 2023;114:163-164
Preanalytic handling of clinical blood samples in assessing immunological proteins - Role of storage duration
Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Preprint: MEDRXIV. 2023
Disrupted-in-schizophrenia 1 (DISC1) protein aggregates in cerebrospinal fluid are elevated in first-episode psychosis patients
Pils M; Rutsch J; Eren F; Engberg G; Piehl F; Cervenka S; Sellgren C; Troßbach S; Willbold D; Erhardt S; Bannach O; Korth C
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2022;47:378-379
Proteomic Plasma Profiling of Patients With First-Episode Psychosis Identifies Inflammatory Markers Associated With Illness Severity
Erhardt S; Schwieler L; Sellgren CM; Eren F; Cervenka S; Piehl F; Bergman HF; Orhan F; Engberg G
Letter: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2022;76(10):526-527
No evidence for transmission of psychosis, bipolar or depressive disorder via hematopoietic stem cell transplantation: A Swedish registry study
Ekstrom LD; Pahnke S; Larfors G; Hagglund H; Lekander M; Edgren G; Cervenka S
Review: BJPSYCH OPEN. 2022;8(5):e159
Exhaustion disorder: scoping review of research on a recently introduced stress-related diagnosis
Lindsater E; Svardman F; Wallert J; Ivanova EN; Soderholm A; Fondberg R; Nilsonne G; Cervenka S; Lekander M; Ruck C
Review: TRANSLATIONAL PSYCHIATRY. 2022;12(1):248
Application of positron emission tomography in psychiatry-methodological developments and future directions
Cervenka S; Frick A; Boden R; Lubberink M
Preprint: PSYARXIV. 2022
Exhaustion Disorder: A Scoping Review of Research on a Recently Introduced Stress-Related Diagnosis
Lindsäter E; Svärdman F; Wallert J; Ivanova EN; Söderholm A; Fondberg R; Nilsonne G; Cervenka S; Lekander M; Ruck C
Preprint: MEDRXIV. 2022
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Schijven D; Postema MC; Fukunaga M; Matsumoto J; Miura K; de Zwarte SMC; van Haren NEM; Cahn W; Pol HEH; Kahn RS; Ayesa-Arriola R; de la Foz VO-G; Tordesillas-Gutierrez D; Vázquez-Bourgon J; Crespo-Facorro B; Alnæs D; Dahl A; Westlye LT; Agartz I; Andreassen OA; Jönsson EG; Kochunov P; Bruggemann JM; Catts SV; Michie PT; Mowry BJ; Quidé Y; Rasser PE; Schall U; Scott RJ; Carr VJ; Green MJ; Henskens FA; Loughland CM; Pantelis C; Weickert CS; Weickert TW; de Haan L; Brosch K; Pfarr J-K; Ringwald KG; Stein F; Jansen A; Kircher TTJ; Nenadic I; Krämer B; Gruber O; Satterthwaite TD; Bustillo J; Mathalon DH; Preda A; Calhoun VD; Ford JM; Potkin SG; Chen J; Tan Y; Wang Z; Xiang H; Fan F; Bernardoni F; Ehrlich S; Fuentes-Claramonte P; Garcia-Leon MA; Guerrero-Pedraza A; Salvador R; Sarró S; Pomarol-Clotet E; Ciullo V; Piras F; Vecchio D; Banaj N; Spalletta G; Michielse S; van Amelsvoort T; Dickie EW; Voineskos AN; Sim K; Ciufolini S; Dazzan P; Murray RM; Kim W-S; Chung Y-C; Andreou C; Schmidt A; Borgwardt S; McIntosh AM; Whalley HC; Lawrie SM; du Plessis S; Luckhoff HK; Scheffler F; Emsley R; Grotegerd D; Lencer R; Dannlowski U; Edmond JT; Rootes-Murdy K; Stephen JM; Mayer AR; Antonucci LA; Fazio L; Pergola G; Bertolino A; Díaz-Caneja CM; Janssen J; Lois NG; Arango C; Tomyshev AS; Lebedeva I; Cervenka S; Sellgren CM; Georgiadis F; Kirschner M; Kaiser S; Hajek T; Skoch A; Spaniel F; Kim M; Bin Kwak Y; Oh S; Kwon JS; James A; Bakker G; Knöchel C; Stäblein M; Oertel V; Uhlmann A; Howells FM; Stein DJ; Temmingh HS; Diaz-Zuluaga AM; Pineda-Zapata JA; López-Jaramillo C; Homan S; Ji E; Surbeck W; Homan P; Fisher SE; Franke B; Glahn DC; Gur RC; Hashimoto R; Jahanshad N; Luders E; Medland SE; Thompson PM; Turner JA; van Erp TGM; Francks C
Corrigendum: MOLECULAR PSYCHIATRY. 2022;27(3):1855
GRK3 deficiency elicits brain immune activation and psychosis (May, 10.1038/s41380-021-01106-0, 2021)
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hokfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landen M; Engberg G; Erhardt S
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S132-S133
Cytomegalovirus infection and IQ in adolescents with early-onset psychosis
Calkova T; Cervenka S; Yolken RH; Andreassen OA; Andreou D
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):228-229
Meta-analysis of the glial marker TSPO in psychosis revisited: Reconciling inconclusive findings of patient-control differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; de'Picker L; Rusjan PM; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):258-260
Validation of kinfitr: An open-source tool for reproducible PET kinetic modelling
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):205-206
Non-displacable binding is a potential confounding factor in [¹¹C]PBR28 PET studies
Laurell GL; Plaven-Sigray P; Jucaite A; Varrone A; Cosgrove KP; Svarer C; Knudsen GM; Ogden RT; Zanderigo F; Cervenka S; Hillmer AT; Schain M
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):260-261
Lower thalamic dopamine D2-receptor binding and connectivity in drug-naive patients with psychosis - A combined [11C]FLB 457 PET and DTI study
Victorsson P; Plaven-Sigray P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Preprint: MEDRXIV. 2021
Cerebrospinal fluid concentration of complement component 4A is increased in first-episode schizophrenia
Gracias J; Orhan F; Hörbeck E; Holmén-Larsson J; Khanlarkani N; Malwade S; Goparaju S; Schwieler L; Fatourus-Bergman H; Pelanis A; Goold C; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yañez VC; Göpfert J; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan S; Perlis R; Cervenka S; Erhardt S; Landen M; Sellgren C
Editorial comment: BRAIN BEHAVIOR AND IMMUNITY. 2021;93:8-9
Effects of acute glial cell activation on memory performance - Implications for treatment of cognitive symptoms in neurological and psychiatric disorders
Cervenka S
Letter: BIOLOGICAL PSYCHIATRY. 2021;89(3):e5-e8
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; De Picker L; Rusjan P; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Book chapter: PET AND SPECT IN PSYCHIATRY. 2021;p. 589-606
TSPO Imaging in Psychiatric Disorders
Cervenka S; Mizrahi R
Review: LANCET PSYCHIATRY. 2020;7(12):1064-1074
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Meyer JH; Cervenka S; Kim M-J; Kreisl WC; Henter ID; Innis RB
Preprint: RESEARCH SQUARE. 2020
Reliability of Dopamine Transporter PET Measurements with [18F]FE-PE2I in patients with Parkinson´s Disease
Kerstens V; Fazio P; Sundgren M; Matheson G; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Preprint: BIORXIV. 2020
Low convergent validity of [₁₁C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [₁₁C]FLB 457
Freiburghaus T; Svensson J; Matheson G; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Preprint: RESEARCH SQUARE. 2020
Reliability of Dopamine Transporter PET Measurements with [18F]FE-PE2I in patients with Parkinson's Disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Preprint: BIORXIV. 2020
Cortical Thickness Trajectories across the Lifespan: Data from 17,075 healthy individuals aged 3-90 years
Frangou S; Modabbernia A; Doucet G; Papachristou E; Williams SCR; Agartz I; Aghajani M; Akudjedu T; Albajes-Eizagirre A; Alnæs D; Alpert K; Andersson M; Andreasen N; Andreassen O; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma D; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer R; Buitelaar J; Busatto G; Buckner R; Calhoun V; Canales-Rodríguez E; Cannon D; Caseras X; Castellanos F; Cervenka S; Chaim-Avancini T; Ching CRK; Clark V; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EAM; Dale A; Davey C; de Geus EJC; de Haan L; de Zubicaray G; Braber AD; Dickie E; Di Giorgio A; Doan NT; Dørum E; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher S; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn D; Gotlib I; Grabe H-J; Grimm O; Groenewold N; Grotegerd D; Gruber O; Gruner P; Gur R; Gur R; Harrison B; Hartman C; Hatton S; Heinz A; Heslenfeld D; Hibar D; Hickie I; Ho B-C; Hoekstra P; Hohmann S; Holmes A; Hoogman M; Hosten N; Howells F; Hulshoff Pol H; Huyser C; Jahanshad N; James A; Jiang J; Jönsson E; Joska J; Kahn R; Kalnin A; Kanai R; Kang S; Klein M; Klushnik T; Koenders L; Koops S; Krämer B; Kuntsi J; Lagopoulos J; Lázaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin N; Martínez-Zalacaín I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald B; McIntosh A; McMahon K; McPhilemy G; Menchón J; Medland S; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik J; Nyberg L; Oosterlaan J; de la Foz VO-G; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella M; Potkin S; Radua J; Reif A; Roffman J; Rosa PGP; Sacchet M; Sachdev P; Salvador R; Sánchez-Juan P; Sarró S; Satterthwaite T; Saykin A; Serpa M; Schmaal L; Schnell K; Schumann G; Smoller J; Sommer I; Soriano-Mas C; Stein D; Strike L; Swagerman S; Tamnes C; Temmingh H; Thomopoulos S; Tomyshev A; Tordesillas-Gutiérrez D; Trollor J; Turner J; Uhlmann A; van den Heuvel O; van den Meer D; van der Wee NJA; van Haren NEM; van ’t Ent D; van Erp TGM; Veer I; Veltman D; Völzke H; Walter H; Walton E; Wang L; Wang Y; Wassink T; Weber B; Wen W; West J; Westlye L; Whalley H; Wierenga L; Wittfeld K; Wolf D; Wright M; Yang K; Yoncheva Y; Zanetti M; Ziegler G; Thompson P; Dima D
Preprint: BIORXIV. 2020
Subcortical Volume Trajectories across the Lifespan: Data from 18,605 healthy individuals aged 3-90 years
Dima D; Papachristou E; Modabbernia A; Doucet G; Agartz I; Aghajani M; Akudjedu T; Albajes-Eizagirre A; Alnæs D; Alpert K; Andersson M; Andreasen N; Andreassen O; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma D; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer R; Buitelaar J; Busatto G; Buckner R; Calhoun V; Canales-Rodríguez E; Cannon D; Caseras X; Castellanos F; Cervenka S; Chaim-Avancini T; Ching CRK; Clark V; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EAM; Dale A; Davey C; de Geus EJC; de Haan L; de Zubicaray G; den Braber A; Dickie E; Di Giorgio A; Doan NT; Dørum E; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher S; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn D; Gotlib I; Grabe H-J; Grimm O; Groenewold N; Grotegerd D; Gruber O; Gruner P; Gur R; Gur R; Harrison B; Hartman C; Hatton S; Heinz A; Heslenfeld D; Hibar D; Hickie I; Ho B-C; Hoekstra P; Hohmann S; Holmes A; Hoogman M; Hosten N; Howells F; Hulshoff Pol H; Huyser C; Jahanshad N; James A; Jiang J; Jönsson E; Joska J; Kahn R; Kalnin A; Kanai R; Kang S; Klein M; Klushnik T; Koenders L; Koops S; Krämer B; Kuntsi J; Lagopoulos J; Lázaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin N; Martínez-Zalacaín I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald B; McIntosh A; McMahon K; McPhilemy G; Menchón J; Medland S; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik J; Nyberg L; Oosterlaan J; de la Foz VO-G; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella M; Potkin S; Radua J; Reif A; Roffman J; Rosa PGP; Sacchet M; Sachdev P; Salvador R; Sánchez-Juan P; Sarró S; Satterthwaite T; Saykin A; Serpa M; Schmaal L; Schnell K; Schumann G; Smoller J; Sommer I; Soriano-Mas C; Stein D; Strike L; Swagerman S; Tamnes C; Temmingh H; Thomopoulos S; Tomyshev A; Tordesillas-Gutiérrez D; Trollor J; Turner J; Uhlmann A; van den Heuvel O; van den Meer D; van der Wee NJA; van Haren NEM; van ’t Ent D; van Erp TGM; Veer I; Veltman D; Völzke H; Walter H; Walton E; Wang L; Wang Y; Wassink T; Weber B; Wen W; West J; Westlye L; Whalley H; Wierenga L; Williams SCR; Wittfeld K; Wolf D; Worker A; Wright M; Yang K; Yoncheva Y; Zanetti M; Ziegler G; Thompson P; Frangou S
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27:385
Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls
Theorell J; Ramberger M; Harrison R; Mgbachi V; Jacobson L; Waters P; Cervenka S; Irani SR; Piehl F
Conference publication: SCHIZOPHRENIA BULLETIN. 2020;46:S233
UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
Plaven-Sigray P; Matheson G; Coughlin J; Hafizi S; Laurikainen H; Ottoy J; de'Picker L; Rusjan P; Hietala J; Howes O; Mizrahi R; Morrens M; Pomper M; Cervenka S
Conference publication: SCHIZOPHRENIA BULLETIN. 2020;46:S135-S136
LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS - A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
Victorsson P; Plaven-Sigray P; Matheson G; Santillo A; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Preprint: BIORXIV. 2020
Kinfitr – an open source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Letter: NEUROIMAGE. 2020;207:116371
In response to the letter "[¹¹C]raclopride and extrastriatal binding to D2/3 receptors"
Svensson JE; Schain M; Plaven-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Corrigendum: NATURE NEUROSCIENCE. 2020;23(2):295
Common brain disorders are associated with heritable patterns of apparent aging of the brain (vol 22, pg 1617, 2019)
Kaufmann T; van der Meer D; Nhat TD; Schwarz E; Lund MJ; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Boen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Cordova-Palomera A; Dale AM; de Quervain DJF; Di Carlo P; Djurovic S; Dorum ES; Eisenacher S; Elvsashagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Haberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jernigan TL; Jonassen R; Jonsson EG; Kirsch P; Kloszewska I; Kolskar KK; Landro NI; Le Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbaek G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT
Letter: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(2):502-504
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
Matheson GJ; Plaven-Sigray P; Tuisku J; Rinne J; Matuskey D; Cervenka S
Book chapter: NEUROIMAGING IN SCHIZOPHRENIA. 2020;p. 145-159
Molecular Imaging
Cervenka S; Farde L
Preprint: BIORXIV. 2019
The genetic architecture of human brainstem structures and their involvement in common brain disorders
Elvsåshagen T; Bahrami S; van der Meer D; Agartz I; Alnæs D; Barch D; Baur-Streubel R; Bertolino A; Beyer M; Blasi G; Borgwardt S; Boye B; Buitelaar J; Bøen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Carlo PD; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman C; Håberg A; Heslenfeld D; Hoekstra P; Høgestøl E; Jonassen R; Jönsson E; Karolinska Schizophrenia Project (KaSP) consortium; Kirsch P; Kłoszewska I; Lagerberg TV; Landrø NI; Hellard SL; Lesch K-P; Maglanoc L; Malt U; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; O’Connell K; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin A; Schmidt A; Schwarz E; Selbæk G; Soininen H; Sowa P; Steen V; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler G; Zink M; Andreassen O; Westlye L; Kaufmann T
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(SUPPL 1):S392-S393
Reliability of Dopamine Transporter PET Measurements with [¹⁸F]FE-PE2I in Early Stage Parkinson's Disease: A Preliminary Test-Retest Evaluation
Kerstens V; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Corrigendum: PSYCHOLOGICAL MEDICINE. 2019;49(9):1583-1584
Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?: A commentary on 'Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging' (vol 49, pg 1624, 2019)
Plaven-Sigray P; Cervenka S
Editorial comment: PSYCHOLOGICAL MEDICINE. 2019;49(10):1624-1628
Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears? A commentary on 'Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging' by Marques et al.
Plaven-Sigray P; Cervenka S
Letter: SCHIZOPHRENIA RESEARCH. 2019;208:490-492
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis
Santillo AF; Lundgren S; Xu C; Orhan F; Fatouros-Bergman H; Blennow K; Zetterberg H; Portelius E; Cervenka S; Jonsson EG; Erhardt S; Engberg G
Preprint: BIORXIV. 2019
Brain age prediction reveals aberrant brain white matter in schizophrenia and bipolar disorder: A multi-sample diffusion tensor imaging study
Tønnesen S; Kaufmann T; de Lange A-M; Richard G; Doan NT; Alnæs D; van der Meer D; Rokicki J; Moberget T; Maximov II; Agartz I; Aminoff SR; Beck D; Barch D; Beresniewicz J; Cervenka S; Bergman HF; Craven AR; Flyckt L; Gurholt TP; Haukvik UK; Hugdahl K; Johnsen E; Jönsson EG; Kolskår KK; Kompus K; Kroken RA; Lagerberg TV; Løberg E-M; Nordvik JE; Sanders A-M; Ulrichsen K; Andreassen OA; Westlye LT
Preprint: BIORXIV. 2019
Validity and reliability of extrastriatal [¹¹C]raclopride binding quantification in the living human brain
Svensson J; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Conference publication: SCHIZOPHRENIA BULLETIN. 2019;45:S109-S110
MOLECULAR IMAGING STUDIES OF TSPO IN SCHIZOPHRENIA - RELATIONSHIP TO CENTRAL AND PERIPHERAL IMMUNE MARKERS AND NEW METHODS OF QUANTIFICATION
Cervenka S
Letter: BIOLOGICAL PSYCHIATRY. 2019;85(7):e35-e39
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?
van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Clark VP; Mueller BA; de Zwarte SMC; Ophoff RA; van Haren NEM; Andreassen OA; Gurholt TP; Gruber O; Kraemer B; Richter A; Calhoun VD; Crespo-Facorro B; Roiz-Santianez R; Tordesillas-Gutierrez D; Loughland C; Catts S; Fullerton JM; Green MJ; Henskens F; Jablensky A; Mowry BJ; Pantelis C; Quide Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Weickert CS; Weickert TW; Hong E; Kochunov P; Gur RE; Gur RC; Ford JM; Macciardi F; Mathalon DH; Potkin SG; Preda A; Fan F; Ehrlich S; King MD; De Haan L; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; Pomarol-Clotet E; Kelly S; Ciufolini S; Radua J; Murray R; Marques TR; Simmons A; Borgwardt S; Schoenborn-Harrisberger F; Riecher-Roessler A; Smieskova R; Alpert KI; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Yun J-Y; Cannon DM; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; McIntosh AM; Whalley HC; Knoechel C; Oertel-Knoechel V; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA; Farde L; Flyckt L; Fatouros-Bergman H; Cervenka S; Collste K; Victorsson P; Engberg G; Erhardt S; Schwieler L; Malmqvist A; Hedberg M; Orhan F; Piehl F; Agartz I
Preprint: BIORXIV. 2019
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study
Tuisku J; Plavén-Sigray P; Gaiser EC; Airas L; Al-Abdulrasul H; Brück A; Carson RE; Chen M-K; Cosgrove KP; Ekblad L; Esterlis I; Farde L; Forsberg A; Halldin C; Helin S; Kosek E; Lekander M; Lindgren N; Marjamäki P; Rissanen E; Sucksdorff M; Varrone A; Rinne J; Matuskey D; Cervenka S
Conference publication: BRAIN BEHAVIOR AND IMMUNITY. 2019;76:E12-E13
Impaired cognition and fatigue; the role of sleep and neuroinflammation for non-specific symptoms in allergy
Tamm SR; Cervenka S; Forsberg A; Estelius J; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Lensmar C; Strand V; Akerstedt T; Halldin C; Ingvar M; Hoglund CO; Lekander M
Review: NEUROSCIENCE LETTERS. 2019;691:26-34
PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders
Cervenka S
Editorial comment: BRAIN BEHAVIOR AND IMMUNITY. 2018;74:43-44
Immune sculpting of the psychotic brain? In vivo associations between a glial cell marker and hippocampal morphology
Cervenka S
Preprint: BIORXIV. 2018
The dark side of the mean: brain structural heterogeneity in schizophrenia and its polygenic risk
Alnæs D; Kaufmann T; van der Meer D; Córdova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch D; Bertolino A; Brandt C; Cervenka S; Djurovic S; Doan NT; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jönsson E; KaSP Consortium; Kirsch P; Lund M; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland O; Quarto T; Zink M; Andreassen O; Westlye L
Letter: SCHIZOPHRENIA RESEARCH. 2018;199:438-441
Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients
Checa A; Malmqvist A; Flyckt L; Schwieler L; Samuelsson M; Skogh E; Cervenka S; Dahl M-L; Piehl F; Erhardt S; Wheelock CE
Preprint: ARXIV. 2018
Deep Learning for Quality Control of Subcortical Brain 3D Shape Models
Petrov D; Kuznetsov BAGE; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite TD; Andreassen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutierrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Ehrlich S; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rossler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodriguez EJ; Salvador R; Huang AJ; Roiz-Santianez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Walton E; Thompson PM
Preprint: BIORXIV. 2018
Deep Learning for Quality Control of Subcortical Brain 3D Shape Models
Consortium TE; Petrov D; Gutman BA; Kuznetsov E; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite TD; Andreassen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutirrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Ehrlich S; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rössler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodrguez EJ; Salvador R; Huang AJ; Roiz-Santiaez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Walton E; Thompson PM; consortium FTE
Preprint: BIORXIV. 2018
Accuracy and reliability of [¹¹C]PBR28 specific binding estimated without the use of a reference region
Plaven-Sigray P; Schain M; Zanderigo F; Karolinska [11C]PBR28 study group; Rabiner I; Gunn R; Ogden T; Cervenka S
Preprint: BIORXIV. 2018
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plavén-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Letter: SCHIZOPHRENIA RESEARCH. 2018;195:406-408
First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction
Orhan F; Fatouros-Bergman H; Schwieler L; Cervenka S; Flyckt L; Sellgren CM; Engberg G; Erhardt S
Review: PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2018;373(1744):20170156
Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders
Farde L; Plaven-Sigray P; Borg J; Cervenka S
Preprint: BIORXIV. 2018
Genetics of brain age suggest an overlap with common brain disorders
Kaufmann T; van der Meer D; Doan NT; Schwarz E; Lund M; Agartz I; Alnæs D; Barch D; Baur-Streubel R; Bertolino A; Bettella F; Beyer M; Bøen E; Borgwardt S; Brandt C; Buitelaar J; Celius E; Cervenka S; Conzelmann A; Córdova-Palomera A; Dale A; de Quervain DJ-F; Di Carlo P; Djurovic S; Dørum E; Eisenacher S; Elvsåshagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Håberg A; Harbo H; Hartman C; Heslenfeld D; Hoekstra P; Høgestøl E; Jernigan T; Jonassen R; Jönsson E; Karolinska Schizophrenia Project (KaSP); Kirsch P; Kłoszewska I; Kolskår K-K; Landrø NI; Le Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold A; Maglanoc L; Malt U; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom L; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbæk G; Shadrin A; Smeland O; Soininen H; Sowa P; Steen V; Tsolaki M; Ulrichsen K; Vellas B; Wang L; Westman E; Ziegler G; Zink M; Andreassen O; Westlye L; for the Alzheimer’s Disease Neuroimaging Initiativ; for the Pediatric Imaging, Neurocognition and Gene; for the AddNeuroMed consortium
Preprint: BIORXIV. 2018
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plavén-Sigray P; Matheson GJ; Cselényi Z; Jučaite A; Farde L; Cervenka S
Preprint: BIORXIV. 2017
PET studies of the glial cell marker TSPO in psychosis patients - a meta-analysis using individual participant data
Plavén-Sigray P; Matheson G; Collste K; Ashok A; Coughlin J; Howes O; Mizrahi R; Pomper M; Rusjan P; Veronese M; Wang Y; Cervenka S
Preprint: BIORXIV. 2017
Serotonin 5-HT_1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Preprint: BIORXIV. 2017
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plavén-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2017;42:S102-S103
PET Studies of TSPO in Schizophrenia - Understanding Initial Findings
Cervenka S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2017;42:S220-S221
First-Episode Psychosis Patients Display Increased Plasma IL-18 That Correlates With Cognitive Dysfunctions
Schwieler L; Orhan F; Fatouros-Bergman H; Cervenka S; Flyckt L; Farde L; Sellgren CM; Engberg G; Erhardt S
Preprint: BIORXIV. 2017
Mapping Cortical Brain Asymmetry in 17,141 Healthy Individuals Worldwide via the ENIGMA Consortium
Kong X-Z; Mathias S; Guadalupe T; Abé C; Agartz I; Akudjedu T; Andre A; Saud A; Allen N; Ames D; Andreassen O; Arias Vasquez A; Armstrong N; Bergo F; Bastin M; Batalla A; Bauer J; Baune B; Baur R; Biederman J; Blaine S; Boedhoe P; Bøen E; Bose A; Bralten J; Brandeis D; Brem S; Brodaty H; Bröhl H; Brooks S; Buitelaar J; Bürger C; Bülow R; Calhoun V; Calvo A; Canales-Rodríguez EJ; Canive J; Cannon D; Caparelli E; Castellanos F; Cavalleri G; Cendes F; Chaim-Avancini TM; Chantiluke K; Chen Q-L; Chen X; Cheng Y; Christakou A; Clark V; Coghill D; Connolly C; Conzelmann A; Cόrdova-Palomera A; Cousijn J; Crow T; Cubillo A; Dannlowski U; de Bruttopilo SA; Zeeuw PD; Deary I; Delanty N; Demeter D; Martino AD; Dickie E; Dietsche B; Doan T; Doherty C; Doyle A; Durston S; Earl E; Ehrlich S; Ekman CJ; Elvsåshagen T; Epstein J; Fair D; Faraone S; Fatouros-Bergman H; Fernndez G; Busatto Filho G; Flyckt L; Forster K; Jean-Paul F; Foxe J; Fuentes-Claramonte P; Fullerton J; Garavan H; Garcia DDS; Gotlib I; Goudriaan A; Jorgen Grabe H; Groenewold N; Grotegerd D; Gruber O; Gurholt T; Haavik J; Hahn T; Hansell N; Harris M; Hartman C; Hernandez MDCV; Heslenfeld D; Hester R; Hibar DP; Ho B-C; Ho T; Hoekstra P; van Holst R; Hoogman M; Hovik M; Howells F; Hugdahl K; Huyser C; Ingvar M; Irwin L; Ishikawa A; James A; Jahanshad N; Jernigan T; Jonsson E; Kahler C; Kaleda V; Kelly C; Kerich M; Keshavan M; Khadka S; Kircher T; Kohls G; Konrad K; Korucuoglu O; Kramer B; Krug A; Kwon JS; Lambregts-Rommelse N; Landen M; Lazaro L; Lebedeva I; Lenroot R; Lesch K-P; Li Q; Lim K; Liu J; Lochner C; London E; Lonning V; Lorenzetti V; Luciano M; Luijten M; Lundervold A; Mackey S; MacMaster F; Maingault S; Malpas C; Malt U; Mataix-Cols D; Martin-Santos R; Mayer A; McCarthy H; Mitchell P; Mueller B; Maniega SM; Mazoyer B; McDonald C; McLellan Q; McMahon K; McPhilemy G; Momenan R; Morales A; Narayanaswamy J; Moreira JCV; Nerland S; Nestor L; Nigg J; Nordvik J-E; Novotny S; Oberwelland E; O'Gorman R; Oosterlaan J; Oranje B; Orr C; Overs B; Pauli P; Paulus M; Plessen K; von Polier G; Pomarol-Clotet E; Qiu J; Radua J; Ramos-Quiroga JA; Reddy YCJ; Reif A; Roberts G; Rosa P; Rubia K; Sacchet M; Sachdev P; Salvador R; Schmaal L; Schweren L; Seidman L; Seitz J; Serpa MH; Shaw P; Shumskaya E; Silk T; Simmons A; Simulionyte E; Sinha R; Sjoerds Z; Smelror RE; Soliva JC; Solowij N; Sponheim S; Stein D; Stein E; Stevens M; Strike L; Sudre G; Sui J; Tamm L; Temmingh H; Thoma R; Tomyshev A; Tronchin G; Turner J; Uhlmann A; van Erp TGM; van den Heuvel O; van der Meer D; van Eijk L; Vance A; Veer I; Dic
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S722
Associations between central chemokine levels and glial activation in first episode psychosis - a positron emission tomography study
Collste K; Orhan F; Erhardt S; Schwieler L; Flyckt L; Farde L; Engberg G; Cervenka S
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2017;44:S522
Radiosynthesis of 6-[¹⁸F]Fluoro-α-methyl-L-tryptophan - a prospective tracer for in vivo studies of tryptophan metabolism
Vazquez-Romero A; Revunov E; Krasikova R; Moein MM; Cervenka S; Erhardt S; Halldin C; Schou M
Corrigendum: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(4):399
Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein (vol 3, pg 449, 2015)
van der Doef TF; Doorduin J; van Berckel BNM; Cervenka S
Preprint: BIORXIV. 2017
Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging
Petrov D; Gutman BA; Yu S-H; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite T; Andreasen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutiérrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rössler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodríguez EJ; Salvador R; Huang AJ; Roiz-Santiañez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Thompson PM; consortium FTE
Preprint: ARXIV. 2017
Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging
Petrov D; Gutman BA; Shih-Hua; Yu; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite TD; Andreasen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutierrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Ehrlich S; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rossler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodriguez EJ; Salvador R; Huang AJ; Roiz-Santianez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Walton E; Thompson PM
Review: AGEING RESEARCH REVIEWS. 2017;36:50-63
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:234
Reduced TSPO levels in drug-naive first episode psychosis patients as measured using PET and [¹¹C]PBR28
Collste K; Plaven-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:165-166
Assessment of the reliability and validity of simplified ratio-based quantification approaches for [¹¹C]PBR28
Matheson GJ; Sigray PP; Forsberg A; Collste K; Varrone A; Halldin C; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:237
Serotonin 5HT_1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian inference
Griffioen G; Borg J; Matheson GJ; Cervenka S; Farde L
Conference publication: BRAIN BEHAVIOR AND IMMUNITY. 2016;57:E38
Cross-sectional and longitudinal associations between immune cells in blood and brain - A TSPO PET study in healthy control subjects
Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Hoglund CO; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
Conference publication: INTERNATIONAL JOURNAL OF PSYCHOLOGY. 2016;51:879
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:674-675
ASSESSING THE DOPAMINERGIC BASIS OF DELUSIONAL IDEATION: THE RELATIONSHIP BETWEEN D1 AND D2 RECEPTOR AVAILABILITY AND DELUSIONAL BELIEFS IN HEALTHY SUBJECTS
Matheson GJ; Louzolo A; Plaven-Sigray P; Stenkrona P; Farde L; Ingvar M; Petrovic P; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:677-678
ELEVATED LEVELS OF ORBITOFRONTAL DOPAMINE D2-RECEPTORS IN PATIENTS WITH SOCIAL ANXIETY DISORDER
Sigray PP; Hedman E; Ikonen P; Matheson G; Forsberg A; Djurfeldt D; Ruck C; Halldin C; Lindefors N; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:676
PET STUDY OF THALAMIC DOPAMINE D2-RECEPTORS IN DRUG-NAIVE PATIENTS WITH SCHIZOPHRENIA
Ikonen P; Cervenka S; Collste K; Fatouros-Bergman H; Matheson G; Sigray PP; Varrone A; Halldin C; Flyckt L; Farde L
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:639-640
TOWARDS LESS-INVASIVE QUANTIFICATION OF [11C]PBR28: IMAGE-DERIVED AND POPULATION-BASED INPUT FUNCTIONS
Kanegawa N; Schain M; Collste K; Amini N; Takano A; Halldin C; Cervenka S; Farde L; Varrone A
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:675-676
DIURNAL AND SEASONAL VARIATION OF THE BRAIN SEROTONIN SYSTEM IN HEALTHY MALE SUBJECTS
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Review: LAKARTIDNINGEN. 2015;112:DH34
[New findings about schizophrenia can provide new diagnostics and treatment].
Schalling M; Engberg G; Andreassen O; Erhardt S; Cunningham J; Agartz I; Petrovic P; Cervenka S; Fatouros-Bergman H
Conference publication: CHEMICAL SENSES. 2015;40(7):580
Decreased Dopamine Receptor D2 Binding Potential is Associated with Better Olfactory Function
Niman A; Cervenka S; Willander J; Backman L; Farde L; Larsson M
Letter: LAKARTIDNINGEN. 2015;112:DEEX
["Dialogical floor" can become a trap door].
Guterstam J; Hammarberg A; Finn SW; Cervenka S; Lekander M; Petrovic P; Hedman E
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2015;3(6):449-460
Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein
van der Doef TF; Doorduin J; van Berckel BNM; Cervenka S
Letter: LAKARTIDNINGEN. 2013;110(32-33):1416-1417
[Greater clarity on scientific competence is needed].
Cervenka S; Runeson B; Lönnqvist P; Hedlund A; Grönvall KE; Flyckt L
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:S55
Amphetamine-opioid interactions in the human brain reward system - a PET study using [¹¹C]carfentanil
Guterstam J; Jayaram-Lindstrom N; Cervenka S; Halldin C; Farde L; Frost J; Franck J
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2009;29:S575-S576
A comparison of grey matter density in restless legs syndrome patients and matched controls, using FSL-VBM
Comley R; Cervenka S; Palhagen S; Panagiotidis G; Matthews J; Lai R; Halldin C; Farde L; Nichols T; Whitcher B
Published conference paper: NEUROPSYCHOLOGIA. 2009;47(11):2299-2304
Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning
MacDonald SWS; Cervenka S; Farde L; Nyberg L; Backman L
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S7-S8
Limbic dopamine D2-receptor binding and social desirability
Cervenka S; Halldin C; Farde L
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2008;11:222-223
Evidence of functional compartmentalization of the human striatum: subregional dopamine D2-receptor binding in relation to cognition
Cervenka S; Backman L; Cselenyi Z; Halldin C; Farde L
Doctoral thesis: 2008
Dopamine D2-receptor mapping in restless legs syndrome and human behaviour
Cervenka S
Meeting abstract: NEUROIMAGE. 2006;31:T85
Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction
Sovago J; Farde L; Cervenka S; Halldin C; Gulyas B
Conference publication: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2005;238:S47
Increased dopamine D2-receptor availability in patients with Restless Legs Syndrome as measured with Positron Emission Tomography
Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Matthews JC; Lai RY; Halldin C; Farde L
Show more

Employments

Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2025-2027
Senior Lecturer, Department of Clinical Neuroscience, Karolinska Institutet, 2021-2024

Degrees and Education

Docent, Karolinska Institutet, 2016
Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2008

About me

Research

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI